Geovax Labs Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | 24.3M 33.41M | Capitalization | 8.29M 11.4M |
---|---|---|---|---|---|
Net income 2024 * | -31M -42.62M | Net income 2025 * | -25M -34.38M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-1.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Geovax Labs Inc
Managers | Title | Age | Since |
---|---|---|---|
David Dodd
CEO | Chief Executive Officer | 74 | 10-03-16 |
Mark Reynolds
DFI | Director of Finance/CFO | 62 | 06-09-30 |
Erica Raiden
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert McNally
BRD | Director/Board Member | 76 | 06-11-30 |
Randal Chase
BRD | Director/Board Member | 74 | 15-03-18 |
John Spencer
BRD | Director/Board Member | 83 | 06-09-27 |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |